Authors



Audrey Talley Rostov, MD

Latest:

Keratoconus management: Lessons learned from an unusual time

Timely access to effective diagnosis and cross-linking is key to positive outcomes


Kevin Yang Wu, MD, DMD

Latest:

New therapeutic targets, drug development for RP

Simply slowing disease progression is no longer enough.


C. Randall Harrell, MD

Latest:

Bringing biologics to eye health

Ophthalmologists, optometrists gain nonpharmacological treatment options for some of the eye’s most complex issues, providing better outcomes.


Gangolf Sauder, MD
Gangolf Sauder, MD

Latest:

Throwing everything away ... except the patient and the surgeon

Single-use cataract surgery comes with several safety and quality attributes.


Robert J. Weinstock, MD

Latest:

AI-related innovations for laser cataract technology mark a milestone in history of device

The integration of artificial intelligence in laser cataract technology is shifting the paradigm for the future of cataract surgery and is driving increased precision and improved outcomes for patients.



Edward J. Holland, MD

Latest:

Innovation and the clinician-scientist

A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.


Shu-I Yeh, MD, PhD

Latest:

Novel approaches to treating severe ocular surface and corneal damage

Severe ocular surface and corneal damage an unseen public health burden.


Curt Greeley, OD

Latest:

Taking care of your patients’ eyes in a digital world

It is important for patients to understand what digital eye strain is and its causes.


Maximilian K. Köppe, MD

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

New acrylic implant provides option for patients with endothelial dysfunction.


Vikram Paranjpe MD, MPH

Latest:

BLOG: The PTVT Trial and Clinical Applications

Joseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.


Maryo Kohen, MD

Latest:

The search for an antifibrotic drug for use with pediatric glaucoma devices

Inflammation and scarring are the primary obstacles with pirfenidone.


Lisa M. Nijm, MD, JD​

Latest:

Rethinking dry eye disease with acute steroid treatment

According to Lisa Nijm, MD, JD, patients can benefit from short-term, on-label treatment with a novel loteprednol formulation


Elizabeth Fortin, MD

Latest:

VLOG: Neuro-Ophthalmology interprofessional eConsults

Andrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance


Darren Gregory, MD

Latest:

Special Report: Stevens-Johnson syndrome

Severe ocular involvement demands inflammation control


Zaiba Malik, MD

Latest:

Beyond mentoring: The power of sponsorship and advocacy in ophthalmology

To create lasting change, ophthalmology must embrace the impact of sponsorship and advocacy—empowering the next generation of leaders with not just knowledge, but the opportunities to excel.


Jason R. Chin, OD, FAAO

Latest:

Increasing your practice’s reach, relevance, and revenue with clinical trials

Working as an investigator can prove to be a positive experience for physicians


Carol Nelson, MD

Latest:

Treating traumatic brain injury neuro-optometrically

Physicians note the impact of prism lenses can be life-changing for patients.


Talia R. Kaden, MD​

Latest:

A Case of Neovascular AMD With Recurrent Subretinal Fluid

A retina specialist analyzes a case of neovascular age-related macular degeneration characterized by recurring subretinal fluid.


Sophie J. Bakri, MD

Latest:

Unmet Needs and the Future of Wet AMD Care

Expert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.


Imane Tarib, MD

Latest:

Tackling negotiations for contracts

On the 'Negotiations' episode of RWO: The Podcast, Dr. Lisa Nijm joins Drs. Nicole Bajic and Grayson Armstrong to discuss personal experiences with contract negotiation.


Randolph Young

Latest:

Tear film imager may shift paradigm in the treatment of dry eye disease

TFI employs spectral interference technology to image and map the corneal surface.




Patti Barkey, COE, OCS

Latest:

Pass-through provides vehicle to drive innovation

As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.


Nathan Congdon

Latest:

Children’s mental health and the impact of vision impairment

Two studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.


Douglas Katsev, MD

Latest:

Payment models for imaging: Procedures not covered by insurance policies

Tips to help eye care providers navigate the maze of insurance issues.


Anoud Al Saati, MD

Latest:

Posterior corneal elevation: Is there a role for premium IOLs?

Trifocal IOLs can, if implanted with caution, be suitable for patients with keratoconus.


Adrienne Scott, MD

Latest:

Case 3: Treating nAMD in the Presence of Geographic Atrophy

Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.

© 2025 MJH Life Sciences

All rights reserved.